Skip to content

BML Capital Management, LLC

Follow

13F filer, CIK 1616824, ZIONSVILLE, IN

BML Capital Management, LLC reported $187,619,016 across 20 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-06. Its ten largest share positions make up 89.58% of the portfolio.

Accepted , ingested 13F-HR 0001754960-26-000981

Period
2026-09-30
Reported value
$188M
Holdings
20
Top 10 weight
89.58%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SEERnew+2,186,587$4.88M
CNTBadded+3,291,113$3.62M
PMVPadded+2,000,000$3.34M
LENZnew+283,114$1.09M
KHCadded+10,000$227K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ACRSreduced-1,020,000-$5.37M
AVIRreduced-198,672-$1.04M
JANXreduced-3,835-$66.3K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001754960-26-000981, largest first. % of portfolio is the value over $186,385,341, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,250,000 shares; 2025Q1: 14,250,000 shares; 2025Q2: 14,250,000 shares; 2025Q3: 14,250,000 shares; 2025Q4: 14,250,000 shares; 2026Q1: 14,250,000 shares; 2026Q2: 11,975,000 shares; 2026Q3: 10,955,000 shares 10,955,000$57.6M30.92%-1,020,000Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,608,312 shares; 2025Q1: 7,609,812 shares; 2025Q2: 7,609,812 shares; 2025Q3: 7,473,963 shares; 2025Q4: 7,490,000 shares; 2026Q1: 7,058,657 shares; 2026Q2: 6,952,330 shares; 2026Q3: 6,753,658 shares 6,753,658$35.2M18.88%-198,672Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,669,908 shares; 2026Q3: 6,669,908 shares 6,669,908$13.3M7.16%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,466,684 shares; 2025Q1: 3,747,612 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,292,000 shares; 2025Q4: 5,292,000 shares; 2026Q1: 5,320,000 shares; 2026Q2: 5,330,000 shares; 2026Q3: 7,330,000 shares 7,330,000$12.2M6.57%+2,000,000Timeline
KHCKRAFT HEINZ COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,000 shares; 2026Q2: 465,000 shares; 2026Q3: 475,000 shares 475,000$10.8M5.79%+10,000Timeline
TLYSTILLYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,150,000 shares; 2026Q2: 2,150,000 shares; 2026Q3: 2,150,000 shares 2,150,000$9.95M5.34%0Timeline
KMXCARMAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 155,000 shares; 2026Q1: 155,000 shares; 2026Q2: 172,500 shares; 2026Q3: 172,500 shares 172,500$9.51M5.1%0Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 543,180 shares; 2026Q1: 1,902,201 shares; 2026Q2: 2,519,701 shares; 2026Q3: 2,519,701 shares 2,519,701$7.56M4.06%0Timeline
TGTTARGET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 37,500 shares; 2026Q1: 37,500 shares; 2026Q2: 37,500 shares; 2026Q3: 37,500 shares 37,500$5.88M3.15%0Timeline
SEERSEER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,186,587 shares 2,186,587$4.88M2.62%newTimeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: 416,720 shares; 2025Q2: 534,899 shares; 2025Q3: 645,600 shares; 2025Q4: 645,600 shares; 2026Q1: 645,600 shares; 2026Q2: 645,600 shares; 2026Q3: 645,600 shares 645,600$4.67M2.51%0Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,267,500 shares; 2025Q4: 408,887 shares; 2026Q1: 408,887 shares; 2026Q2: 573,287 shares; 2026Q3: 3,864,400 shares 3,864,400$4.25M2.28%+3,291,113Timeline
ORMPORAMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,643,907 shares; 2025Q1: 3,020,748 shares; 2025Q2: 3,083,253 shares; 2025Q3: 3,167,231 shares; 2025Q4: 3,167,231 shares; 2026Q1: 3,167,231 shares; 2026Q2: 866,269 shares; 2026Q3: 884,392 shares 884,392$4.13M2.22%+18,123Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 154,961 shares; 2026Q2: 154,961 shares; 2026Q3: 151,126 shares 151,126$2.61M1.4%-3,835Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,546,137 shares; 2026Q1: 1,546,137 shares; 2026Q2: 1,546,137 shares; 2026Q3: 1,546,137 shares 1,546,137$1.67M0.9%0Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,271 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 283,114 shares 283,114$1.09M0.58%newTimeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,509 shares; 2025Q4: 177,026 shares; 2026Q1: 200,730 shares; 2026Q2: 200,730 shares; 2026Q3: 200,730 shares 200,730$919K0.49%0Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 71,839 shares 71,839$87.6K0.05%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
TSLATESLA INC COMput150$696K-225
WMTWALMART INC COMput335$538K0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CORZCORE SCIENTIFIC INC NEW800$298Kput

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-26-000981 base2026-11-06